Skip to main content

Table 1 Laboratory findings of the present patient

From: Anemia following zinc treatment for Wilson’s disease: a case report and literature review

 

WBC (*109/L)

Neutrophils (*109/L)

RBC (*109/L)

HGB (g/dL)

PLT (*109/L)

ALT (IU/L)

AST (IU/L)

Serum copper (ug/L)

Serum Zinc (ug/dl)

24-h urine copper (ug)

7ya

6.9

1.35

4.66

13.7

183

324

294

NA

NA

360

7y1m

6.5

1.30

5.0

12.9

194

210

158

NA

NA

NA

7y6m

5.1

1.18

5.1

13.4

185

36

26

NA

NA

NA

8y

6.1

1.24

5.3

14.5

196

43

33

NA

NA

NA

11y 4mb

2.1

0.09

1.6

4.7

159

31

21

127.3

530

NA

11y 10mc

1.5

0.08

1.37

4.0

191

16

17

56.3

500

30

11y 10md

2.2

0.11

2.27

6.7

251

20

18

NA

NA

NA

12y 2 m

4.54

2.27

5.28

11.7

225

13

22

NA

NA

NA

  1. * : multiply by. a: age at initiation of zinc therapy. b: age at onset of anemia. c: age at withdrawal of zinc. d: 1 week after zinc withdrawal. y years, m months, NA not assessed